Physician
Southwest Women's Oncology INC.
Southwest Women's Oncology INC. was paid $514K by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
33Billing provider infoSOUTHWEST WOMEN'S ONCOLOGY INC.
ALBUQUERQUE, NM 87109
ALBUQUERQUE, NM 87109
33aNPI1942372479assigned 11/13/2006
33bProvider typeGynecology Physician
28Total paid$514K
24GClaims9,095
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Gynecology Physician providers in New Mexico
Rank by total paid#1 of 8
Median peer was paid$38K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,553 | $63K | |
| 2019 | 1,599 | $57K | |
| 2020 | 1,354 | $66K | |
| 2021 | 912 | $63K | |
| 2022 | 1,217 | $81K | |
| 2023 | 1,380 | $95K | |
| 2024incomplete | 1,080 | $89K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 3,662 | 3,443 | $286K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 19% | 1,112 | 786 | $97K |
| 99205 | Prolong outpt/office vis | 9.4% | 292 | 289 | $48K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.7% | 662 | 470 | $19K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.0% | 287 | 281 | $15K |
| 96367 | 2.3% | 520 | 380 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 138 | 117 | $11K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.4% | 193 | 129 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.0% | 139 | 91 | $5K |
| 96368 | <1% | 251 | 179 | $3K | |
| 96417 | <1% | 43 | 36 | $2K | |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 109 | 71 | $2K |
15 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $1K |
| S9999 | Sales tax | <1% | 41 | $1K |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 179 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 797 | $1K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 76 | $871.84 |
| 96415 | <1% | 14 | $411.03 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 36 | $354.81 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 14 | $149.43 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 229 | $145.93 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 66 | $114.57 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 32 | $70.18 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 103 | $67.93 |
| J3490 | Unclassified drugs | <1% | 55 | $56.42 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 16 | $17.64 |
| S0028 | Injection, famotidine, 20 mg | <1% | 16 | $5.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINKELSTEIN, KAREN (PRESIDENT)